|
Volumn 84, Issue 4, 1999, Pages 1488-1489
|
Is there a role for low doses of mitotane (o,p', DDD) as adjuvant therapy in adrenocortical carcinoma? - Authors' response [4]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
MITOTANE;
ADRENAL CORTEX CARCINOMA;
CANCER ADJUVANT THERAPY;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG SAFETY;
DRUG TOLERABILITY;
HUMAN;
LETTER;
PRIORITY JOURNAL;
QUALITY OF LIFE;
SURVIVAL RATE;
|
EID: 0033331698
PISSN: 0021972X
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (15)
|
References (1)
|